Putting a POC Troponin to the Test - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Putting a POC Troponin to the Test

Independent verification shows strong precision and concordance with lab assays across clinical thresholds.

  • By

  • Julie Greenbaum

  • February 5, 2026

  • 3 min

Share

Clinical Scorecard: Putting a POC Troponin to the Test

At a Glance

CategoryDetail
ConditionMyocardial Infarction Assessment
Key MechanismsHigh-sensitivity troponin I assay
Target PopulationPatients undergoing assessment for possible myocardial infarction
Care SettingEmergency care and rural/low-resource settings

Key Highlights

  • The TriageTrue hs-TnI assay met manufacturer performance claims.
  • Demonstrated acceptable precision and minimal analytical interference.
  • Strong concordance with laboratory-based assays across clinically relevant thresholds.
  • Correlation coefficients with other assays ranged from 0.89 to 0.99.
  • Assay performance supports incorporation into clinical pathways.

Guideline-Based Recommendations

Diagnosis

  • Utilize the TriageTrue hs-TnI assay for assessing myocardial infarction.

Management

  • Incorporate the assay into clinical pathways for timely diagnosis.

Monitoring & Follow-up

  • Assess intra-assay and inter-analyzer precision regularly.

Risks

  • Logistical constraints in obtaining suitable samples may affect results.

Patient & Prescribing Data

Patients suspected of myocardial infarction.

The assay performs adequately for intended medical use.

Clinical Best Practices

  • Ensure timely analysis of whole blood EDTA samples.
  • Monitor hemolysis levels to minimize interference.

Related Resources & Content

Original Source(s)

Putting a POC Troponin to the Test

  • by Julie Greenbaum

  • February 5, 2026

Related Content

Sex Differences Seen in Immune Cells

Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells

HHS Seeks Broader Access to Health Data

"We can’t do anything our agreements don’t allow us to do"

Can Endotoxin-Targeted Care Improve Sepsis Outcomes?

Biomarker-guided patient selection may help identify patients with sepsis who could benefit from endotoxin-targeted therapy, although confirmatory evidence is still needed.